Frank Stokes Castle Biosciences Inc (CSTL) insider trading activity

CSTL Quotes by TradingView

Frank Stokes is Chief Financial Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 43,365 shares of CSTL, which is worth approximately $1.22 Million. The most recent transaction as insider was on Jan 12, 2021, when has been sold 7,500 shares (Common Stock) at a price of $78.1 per share, resulting in proceeds of $585,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.4K
14.89% 3M change
9.64% 12M change
Total Value Held $1.22 Million

Frank Stokes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2021
SELL
Open market or private sale
$585,750 $78.1 p/Share
7,500 Reduced 65.87%
3,886 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$17,925 $2.39 p/Share
7,500 Added 39.71%
11,386 Common Stock
Jan 11 2021
SELL
Open market or private sale
$586,950 $78.26 p/Share
7,500 Reduced 65.87%
3,886 Common Stock
Jan 11 2021
BUY
Exercise of conversion of derivative security
$17,925 $2.39 p/Share
7,500 Added 39.71%
11,386 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
$6,760 $3.38 p/Share
2,000 Added 33.98%
3,886 Common Stock
Nov 13 2020
SELL
Open market or private sale
$666,250 $51.25 p/Share
13,000 Reduced 87.33%
1,886 Common Stock
Nov 13 2020
BUY
Exercise of conversion of derivative security
$31,070 $2.39 p/Share
13,000 Added 46.62%
14,886 Common Stock
Nov 12 2020
SELL
Open market or private sale
$671,320 $51.64 p/Share
13,000 Reduced 87.33%
1,886 Common Stock
Nov 12 2020
BUY
Exercise of conversion of derivative security
$31,070 $2.39 p/Share
13,000 Added 46.62%
14,886 Common Stock
Oct 14 2020
SELL
Open market or private sale
$705,380 $54.26 p/Share
13,000 Reduced 87.33%
1,886 Common Stock
Oct 14 2020
BUY
Exercise of conversion of derivative security
$31,070 $2.39 p/Share
13,000 Added 46.62%
14,886 Common Stock
Oct 13 2020
SELL
Open market or private sale
$712,270 $54.79 p/Share
13,000 Reduced 87.33%
1,886 Common Stock
Oct 13 2020
BUY
Exercise of conversion of derivative security
$31,070 $2.39 p/Share
13,000 Added 46.62%
14,886 Common Stock

Also insider at

XGN
EXAGEN INC. Healthcare
Director
FS

Frank Stokes

Chief Financial Officer
Friendswood, TX

Track Institutional and Insider Activities on CSTL

Follow CASTLE BIOSCIENCES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

News

Receive news related to CASTLE BIOSCIENCES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CSTL